145 related articles for article (PubMed ID: 33593207)
1. Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors.
Zito Marino F; Brunelli M; Rossi G; Calabrese G; Caliò A; Nardiello P; Martignoni G; Squire JA; Cheng L; Massi D; Franco R
Expert Rev Mol Diagn; 2021 Feb; 21(2):161-173. PubMed ID: 33593207
[No Abstract] [Full Text] [Related]
2. Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples.
Zito Marino F; Rossi G; Cozzolino I; Montella M; Micheli M; Bogina G; Munari E; Brunelli M; Franco R
J Clin Pathol; 2020 Feb; 73(2):96-101. PubMed ID: 31562206
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analysis of two primary squamous cell carcinomas of the lung using multicolor fluorescence in situ hybridization.
Gunawan B; Mirzaie M; Schulten HJ; Heidrich B; Füzesi L
Virchows Arch; 2001 Jul; 439(1):85-9. PubMed ID: 11499845
[TBL] [Abstract][Full Text] [Related]
4. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine in NSCLC and pathology: how does ALK fit in the pathway?
Kerr KM; López-Ríos F
Ann Oncol; 2016 Sep; 27 Suppl 3():iii16-iii24. PubMed ID: 27573752
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide PIK3CA/Chromosome 3 Dual in Situ Hybridization Automated Assay with Improved Signals, One-Hour Hybridization, and No Use of Blocking DNA.
Zhang W; Hubbard A; Baca-Parkinson L; Stanislaw S; Vladich F; Robida MD; Grille JG; Maxwell D; Tsao TS; Carroll W; Gardner T; Clements J; Singh S; Tang L
J Mol Diagn; 2015 Sep; 17(5):496-504. PubMed ID: 26163898
[TBL] [Abstract][Full Text] [Related]
7. [IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?].
Hamard C; Mignard X; Pecuchet N; Mathiot N; Blons H; Laurent-Puig P; Leroy K; Lupo A; Chapron J; Giraud F; Arrondeau J; Goldwasser F; Alifano M; Damotte D; Wislez M
Rev Pneumol Clin; 2018 Oct; 74(5):327-338. PubMed ID: 30343945
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization.
Romeo MS; Sokolova IA; Morrison LE; Zeng C; Barón AE; Hirsch FR; Miller YE; Franklin WA; Varella-Garcia M
J Mol Diagn; 2003 May; 5(2):103-12. PubMed ID: 12707375
[TBL] [Abstract][Full Text] [Related]
9. Multicolor FISH methods in current clinical diagnostics.
Liehr T; Weise A; Hamid AB; Fan X; Klein E; Aust N; Othman MA; Mrasek K; Kosyakova N
Expert Rev Mol Diagn; 2013 Apr; 13(3):251-5. PubMed ID: 23570403
[TBL] [Abstract][Full Text] [Related]
10. Common Fluorescence In Situ Hybridization Applications in Cytology.
Savic S; Bubendorf L
Arch Pathol Lab Med; 2016 Dec; 140(12):1323-1330. PubMed ID: 27479335
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Ali SM; Hensing T; Schrock AB; Allen J; Sanford E; Gowen K; Kulkarni A; He J; Suh JH; Lipson D; Elvin JA; Yelensky R; Chalmers Z; Chmielecki J; Peled N; Klempner SJ; Firozvi K; Frampton GM; Molina JR; Menon S; Brahmer JR; MacMahon H; Nowak J; Ou SH; Zauderer M; Ladanyi M; Zakowski M; Fischbach N; Ross JS; Stephens PJ; Miller VA; Wakelee H; Ganesan S; Salgia R
Oncologist; 2016 Jun; 21(6):762-70. PubMed ID: 27245569
[TBL] [Abstract][Full Text] [Related]
12. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
[TBL] [Abstract][Full Text] [Related]
13. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
Ginestet F; Lambros L; Le Flahec G; Marcorelles P; Uguen A
Clin Lung Cancer; 2018 Sep; 19(5):e647-e653. PubMed ID: 29801706
[TBL] [Abstract][Full Text] [Related]
15. Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology.
Savic S; Glatz K; Schoenegg R; Spieler P; Feichter G; Tamm M; Bubendorf L
Chest; 2006 Jun; 129(6):1629-35. PubMed ID: 16778285
[TBL] [Abstract][Full Text] [Related]
16. Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?
Krause FS; Rauch A; Schrott KM; Engehausen DG
World J Urol; 2006 Sep; 24(4):418-22. PubMed ID: 16688457
[TBL] [Abstract][Full Text] [Related]
17. Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy.
Zito Marino F; Alì G; Facchinetti F; Righi L; Fontanini G; Rossi G; Franco R
Expert Rev Anticancer Ther; 2021 Aug; 21(8):887-900. PubMed ID: 33715580
[No Abstract] [Full Text] [Related]
18. [Multicolor fluorescence in situ hybridization (mFISH].
Michalová K; Zemanová Z; Brezinová J
Cas Lek Cesk; 2001 Mar; 140(4):99-103. PubMed ID: 11284431
[TBL] [Abstract][Full Text] [Related]
19. Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors.
Chrzanowska NM; Kowalewski J; Lewandowska MA
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316657
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic application of FISH to hematological malignancies.
Najfeld V
Cancer Invest; 2003; 21(5):807-14. PubMed ID: 14628438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
